Clearside Biomedical (CLSD) – FDA
-
Clearside Biomedical (CLSD) Reports Significant Progress in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD
-
Clearside Biomedical (CLSD) Highlights Excellent Safety Profile of CLS-AX and Potential for Extended Duration of Effect
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to CLSD Stock Lookup